Semapa Next is a sector-agnostic corporate venture capital firm investing in European-based startups aspiring to become global category leaders, with a primary focus on Series A stage opportunities.
About Semapa Next
Semapa Next is the corporate venture arm of Semapa, the Portuguese industrial holding group, investing in startups whose products align with the parent group’s industrial portfolio across paper, cement, environment, and adjacent technology categories. Healthcare is not a core thesis area, and founders should not approach Semapa Next primarily as a healthcare investor. Relevant healthcare exposure is incidental and most plausible when a founder is building industrial sustainability technology, environmental health, or selectively digital health products with European industrial-channel distribution. Stage focus is typically Series A and B, with checks plausibly in the EUR 1M to 5M range. Physician founders building anything outside the industrial-adjacent thesis should look elsewhere. Geographic posture is Portugal- and Europe-anchored. The realistic entry path is a warm introduction from a Portuguese ecosystem operator, an existing portfolio founder, or a Semapa business unit contact; cold approaches via the parent company website tend to be slow. Founders should arrive with a clear strategic-fit narrative tied to Semapa’s industrial portfolio, defended unit economics, and a willingness to engage with the parent group. Treat Semapa Next as a strategic industrial-aligned partner relevant only for a narrow subset of healthcare-adjacent founders working at the intersection of industry, environment, and health, not as a healthcare-specialty option for the typical physician AI founder.
Founder reviews
Other portfolio companies
Companies in Semapa Next's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Semapa Next? Founders only — share your honest experience (anonymous OK, moderated before publishing).